GLP-1 receptor agonists are transforming obesity treatment
Some GLP1 medications are compounded outside the FDA process and do not meet the same quality or safety standards as FDAapproved drugs
Ribas GS, Manfredini V, de Mari JF, Wayhs CY, Vanzin CS, Biancini GB, Sitta A, Deon M, Wajner M, Vargas CR (2010a) Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation
He's careful not to overclaim the mechanism
Shulman A, Peltonen M, Sjostrom CD, et al
3.1.3 Superoxide-mediated adrenochrome generation Another method applied to investigate superoxide levels is based on the ability of the anion generated during the xanthine oxidase-mediated reaction to oxidize epinephrine